Page last updated: 2024-09-05

farglitazar and muraglitazar

farglitazar has been researched along with muraglitazar in 2 studies

Compound Research Comparison

Studies (farglitazar)	Trials (farglitazar)	Recent Studies (post-2010) (farglitazar)	Studies (muraglitazar)	Trials (muraglitazar)	Recent Studies (post-2010) (muraglitazar)
35	3	5	85	10	25

Protein Interaction Comparison

Protein	Taxonomy	farglitazar (IC50)	muraglitazar (IC50)
Peroxisome proliferator-activated receptor gamma	Homo sapiens (human)		0.1867
Peroxisome proliferator-activated receptor alpha	Homo sapiens (human)		0.22

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chandrasena, G; Chen, S; Cheng, L; Cheng, PT; Devasthale, PV; Doweyko, AM; Farrelly, D; Golla, R; Grover, G; Hariharan, N; Jeon, Y; Ma, Z; Moore, L; Qu, F; Ryono, DE; Seethala, R; Sleph, P; Sun, W; Wang, W; Zhang, H	1
Berthelot, P; Beucher-Gaudin, M; Caignard, DH; Dacquet, C; Farce, A; Géant, A; Hennuyer, N; Ktorza, A; Lebegue, N; Leclerc, V; Pirat, C; Staels, B; Zanirato, G	1

Other Studies

2 other study(ies) available for farglitazar and muraglitazar

Article	Year
Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I. Bioorganic & medicinal chemistry letters, 2007, Apr-15, Volume: 17, Issue:8 Topics: Amino Acids; Animals; Blood Glucose; Glycine; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Mice, Inbred Strains; PPAR alpha; PPAR gamma; Structure-Activity Relationship	2007
Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression. European journal of medicinal chemistry, 2017, Sep-08, Volume: 137 Topics: Animals; Body Weight; Caloric Restriction; Cells, Cultured; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Gene Expression Profiling; Hypoglycemic Agents; Immediate-Early Proteins; Ligands; Male; Mice; Mice, Obese; Molecular Docking Simulation; Molecular Structure; PPAR gamma; Protein Serine-Threonine Kinases; Sirtuin 1; Structure-Activity Relationship	2017

Article

Year

Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I.

Bioorganic & medicinal chemistry letters, 2007, Apr-15, Volume: 17, Issue:8

Topics: Amino Acids; Animals; Blood Glucose; Glycine; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Mice, Inbred Strains; PPAR alpha; PPAR gamma; Structure-Activity Relationship

2007

Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression.

European journal of medicinal chemistry, 2017, Sep-08, Volume: 137

Topics: Animals; Body Weight; Caloric Restriction; Cells, Cultured; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Gene Expression Profiling; Hypoglycemic Agents; Immediate-Early Proteins; Ligands; Male; Mice; Mice, Obese; Molecular Docking Simulation; Molecular Structure; PPAR gamma; Protein Serine-Threonine Kinases; Sirtuin 1; Structure-Activity Relationship

2017